Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

11.30
+0.07000.62%
Volume:121.72K
Turnover:1.38M
Market Cap:565.02M
PE:-9.53
High:11.44
Open:11.26
Low:11.21
Close:11.23
Loading ...
Sep 14, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2020

Major Issues Report

8-K - Current report
Jul 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jul 06, 2020

Major Issues Report

8-K - Current report
Jun 25, 2020

Major Issues Report

8-K - Current report
Jun 23, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 22, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 11, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 10, 2020

Major Issues Report

8-K - Current report
May 08, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 06, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 29, 2020

Major Issues Report

8-K - Current report
Apr 09, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 09, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Mar 04, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Mar 03, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Feb 27, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 27, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]